Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-13-004242
Filing Date
2013-04-11
Accepted
2013-04-11 16:00:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 a2214393z424b5.htm 424B5 524443
2 G856679.JPG g856679.jpg GRAPHIC 11925
  Complete submission text file 0001047469-13-004242.txt   542206
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-182271 | Film No.: 13756307
SIC: 2834 Pharmaceutical Preparations